TY  - JOUR
AU  - Campos-Sandoval, José A
AU  - Gómez-García, María C
AU  - Santos-Jiménez, Juan de Los
AU  - Matés, José M
AU  - Alonso, Francisco J
AU  - Márquez, Javier
PY  - 2021
DO  - 10.1016/j.neuint.2021.105136
UR  - http://hdl.handle.net/10668/18214
T2  - Neurochemistry international
AB  - Glioblastoma remains one of the most challenging and devastating cancers, with only a very small proportion of patients achieving 5-year survival. The current standard of care consists of surgery, followed by radiation therapy with concurrent and...
LA  - en
KW  - Antioxidant
KW  - Glioblastoma
KW  - ROS
KW  - Temozolomide
KW  - Animals
KW  - Antineoplastic Agents, Alkylating
KW  - Antioxidants
KW  - Brain Neoplasms
KW  - Drug Resistance, Neoplasm
KW  - Glioblastoma
KW  - Humans
KW  - Neoplastic Stem Cells
KW  - Reactive Oxygen Species
KW  - Temozolomide
TI  - Antioxidant responses related to temozolomide resistance in glioblastoma.
TY  - research article
VL  - 149
ER  -